Southwest China's Xizang Autonomous Region has done effective work in promoting the development of Tibetan medicine in recent years.

From January to July in 2023, the total output value of 17 Tibetan medicine enterprises reached 1.715 billion yuan RMB, realizing an increase of 21.56% year-on-year. To continuously promote the pilot planting of Tibetan medicinal materials in the north and south mountains of Lhasa, Ganlu Tibetan Medicine Group has currently planted 5 varieties on a pilot basis, covering an area of 16,667㎡.

To guarantee the resources of Tibetan medicinal materials , except the Millin Modern Agricultural Tibetan Medicinal Materials Industrial Park in Nyingchi, a material base in Nangxian of Nyingchi has been constructed, another one in Gyaca of Shannan has finished 70% of the construction, and the import of Tibetan medicinal materials has been strengthened.

The restructuring and reorganization of Tibetan pharmaceutical enterprises have made steady progress. The industrial chain continues to extend, and the content continues to enrich.

The Department of Science and Technology of Xizang Autonomous Region supported 15 basic research and applied basic research projects in the field of Tibetan medicine through the special fund project of Central Guidance for Local Science & Technology Development and the 2023 Science & Technology Plan of Xizang Autonomous Region, supporting 15.76 million yuan RMB of funds and driving 64.36 million yuan RMB of investment.

Information technology has been fully used to promote the inheritance and innovation of Tibetan medicine. The China Tibetan Medicine Resource Database Platform was officially launched on April 6, 2023. Up to now, a total of 1,541 varieties of medicinal materials have been recorded and 319 have been reviewed and released; 590 prescription information has been recorded and 523 have been reviewed and released.

In the next step, Xizang will continue to promote the high-quality development of the Tibetan medicine industry.